Actively Recruiting

Phase Not Applicable
Age: 30Years - 75Years
All Genders
NCT06407245

Efficacy of Exercise Snacks in Real-World Settings in Individuals Living With Type 2 Diabetes

Led by University of British Columbia · Updated on 2024-05-09

80

Participants Needed

1

Research Sites

65 weeks

Total Duration

On this page

Sponsors

U

University of British Columbia

Lead Sponsor

M

McMaster University

Collaborating Sponsor

AI-Summary

What this Trial Is About

To conduct a pilot randomized control trial to determine the feasibility of a 12-week, technology-enabled exercise snacks intervention in adults living with type 2 diabetes in a real-world setting. We will also assess preliminary efficacy based on measures of glycemic control and fitness.

CONDITIONS

Official Title

Efficacy of Exercise Snacks in Real-World Settings in Individuals Living With Type 2 Diabetes

Who Can Participate

Age: 30Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged 30 to 75 years
  • Diagnosed with type 2 diabetes by a physician
  • Physically inactive (less than 150 minutes of moderate-to-vigorous activity per week)
  • Body mass index between 18.5 and 40 kg/m2
  • Taking 3 or fewer glucose-lowering medications (not insulin) at a stable dose for more than 6 months
  • Taking 2 or fewer common cardiovascular medications (e.g., statins, antihypertensives)
  • HbA1c less than or equal to 8.5%
  • Able to keep current physical activity levels during the study
  • Cleared for physical activity using the Get Active Questionnaire or consultation with a healthcare provider or exercise professional
  • Access to a computer, tablet, or smartphone for intervention and tracking
  • Ability to read and write in English
Not Eligible

You will not qualify if you...

  • Chronic musculoskeletal conditions or recent (within 2 years) cardiovascular events preventing exercise
  • No internet access
  • Angina during exertion as assessed by the Rose Angina Questionnaire
  • Taking beta-blockers that affect heart rate measurements during exercise testing
  • Uncontrolled high blood pressure (160/90 mmHg or higher) or abnormal resting or exercise blood pressure or pulse rate
  • Scheduled surgical procedure in the next 3-4 months preventing exercise
  • Diagnosed cardiac or pulmonary diseases preventing exercise (e.g., angina, arrhythmia, exercise-induced bronchospasm)
  • Psychiatric disorders preventing study completion
  • Donated more than 0.5 liters of blood in the last 4 weeks
  • Following extreme diets or taking supplements that affect glucose control
  • Having diabetic ulcers, peripheral vascular disease, or neuropathy preventing exercise
  • Participating in another clinical trial interfering with this study
  • Currently on dialysis
  • Pregnant or planning pregnancy during the study
  • Experienced severe hypoglycemia in the past 6 months requiring assistance

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of British Columbia Okanagan

Kelowna, British Columbia, Canada, V1V 3G1

Actively Recruiting

Loading map...

Research Team

J

Jonathan P Little, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here